Current Issue


VOL 8 • NO 5 JULY/AUG 2017

Editorial

Priming the Pump: Preparing the Advanced Practitioner in Oncology for Scientific Innovation

Sandra Kurtin, PhDc, ANP-C, AOCN®

The unprecedented, almost frenetic pace of scientific innovation relative to the diagnosis and treatment of cancer demands a level of continuous engagement on the part of oncology providers to safely and effectively integrate these changes into practice. There have been 209 US Food and Drug Admin...


Editorial

The Wounded Healer

Morgan Gonzales, LCSW, and Laura Melton, PhD, ABPP

ncology clinicians skillfully and passionately provide services to patients with life-threatening cancer and are impacted daily by pain, loss, trauma, death, and grief. We understand that healing is not exclusively about treating or curing a disease, but also about finding meaning and peace while...


Editorial

The American Society of Clinical Oncology Reports on the State of Cancer Care in America: 2017

Pamela Hallquist Viale, RN, MS, CNS, ANP

he American Society of Clinical Oncology (ASCO) has recently published its State of Cancer Care in America report for the year 2017. This is a yearly compilation of the trends and issues facing cancer care in America, giving readers a thorough look at important challenges and improvements in the ...


Original Research

Developing a Clinical Program Based on the Needs of Patients With Chronic Lymphocytic Leukemia: Preparing for Illness Episodes

Rose Bell, PhD, ARNP-C, AOCNP®

Despite advances in treatment, chronic lymphocytic leukemia (CLL) is a chronic disease that is still considered an inherently incurable hematologic cancer (Abrisqueta, Crespo, & Bosch, 2011; Beusterien et al., 2010; Molica, 2005; Stephens, Gramegna, Laskin, Botteman, & Pashos, 2005). Chro...


Review Article

Cancer Pain Management: Comprehensive Assessment and Nonopioid Analgesics, Part 1

Rita J. Wickham, PhD, RN, AOCN®

About 50% of cancer patients have undertreated pain, and the percentage is even greater among minority patients (Fisch et al., 2012; Paice & Von Roenn, 2014; Stein, Alcaraz, Kamson, Fallon, & Smith, 2015). Unrelieved pain is not inconsequential and can alter immunity and organ function, i...


Review Article

Cancer Care: Supporting Underserved and Financially Burdened Family Caregivers

Betty R. Ferrell, RN, PhD, MA, FAAN, FPCN, CHPN, and Kate Kravitz, RN, HNB-BS, LPC, NCC, ATR-BC

Health-care policies in the United States now mandate earlier hospital discharge following surgery and treatment. For oncology patients, family caregiving is the primary source of care. Not only are family caregivers central to the family member’s diagnosis and treatment, but also to survivorship...


Continuing Education

Continuing Education Information: Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia


Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia  This activity is supported by an educational grant from Pharmacyclics, LLC, an AbbVie Company, and Janssen Biotech, Inc.  A continuing education article for nurse practitioners, clinica...


Grand Rounds

Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia

Sandra Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP

Continuing Education Information Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia  This activity is supported by an educational grant from Pharmacyclics, LLC, an AbbVie Company, and Janssen Biotech, Inc.  A continuing education articl...


Grand Rounds

Treatment of a Locally Invasive Cutaneous Fusarium Species Infection With Voriconazole and Liposomal Amphotericin B in a Patient With Relapsed Acute Myeloid Leukemia

Sara Anne Meyer, PharmD, BCPS, and Bruce M. Jones, PharmD, BCPS

The Fusarium genus, which causes various human diseases, including mycotoxicosis and locally invasive or disseminated infections, is a saprophyte commonly found in soil. Influenced by host immune status, the Fusarium fungi may lead to disseminated, life-threatening, disease. In immunocompromised ...


Practice Matters

Instruments That Predict Oncology Treatment Risk in the Senior Population

Jessica K. Schiefen, MSN, RN, FNP-C, AOCNP®, Lydia T. Madsen, PhD, RN, AOCNS®, FNAP, and Joyce E. Dains, DrPH, JD, RN, FNP-BC, FNAP, FAANP

By 2030, an estimated one out of five Americans will be over 65 years of age. An expanding senior population will profoundly impact the health-care system related to cancer care (Centers for Disease Control and Prevention, 2013). Cancer is both a disease associated with aging and the leading caus...


Prescriber's Corner

Use of Atezolizumab for Bladder and Non–Small Cell Lung Cancers

Kayla Faith Moore, PharmD

Atezolizumab (Tecentriq) is an immunotherapy agent with activity across a broad range of tumor types including bladder and non–small cell lung cancer (NSCLC). Recently, immunotherapy has shown a promising avenue of clinical research in both of these disease states. Background on bladder and lung...


Tools and Technology

Starting an Advanced Practice Provider Professional Writing Group

Lydia T. Madsen, PhD, RN, AOCNS®, FNAP, and Kristen Starnes-Ott, PhD, BS, CRNA

A work-related professional writing group presents the opportunity for would-be authors to focus on expertise while fostering collegiality and productivity among colleagues. Across many disciplines, including nursing, the routine practice of individual writing and then meeting as a group to revie...


 

 

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me